progesterone · Ferring · NDA 022057
Endometrin
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 216363, Glenmark Pharms · 022057-001Approved 8 Apr 2026Detected 25 Oct 2026Historical import
- Generic approved · ANDA 219588, Novast Labs · 022057-001Approved 16 Oct 2026Detected 25 Oct 2026Historical import
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022057 · 001 · RLD | insert, vaginal | 100MG | open |